Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | FIST | HIV Therapy Patent Landscape 2009

HIV Therapy Patent Landscape 2009

IP Overview presents a patent landscape analysis of the HIV Therapy field.

Discovered in 1983, the HIV virus has been the subject of intensive research and development within the academic and industrial sectors. With the perspective of a global market of 10 billion US$, applicants filed more than 6800 patents and patent applications.

Protease and Reverse Transcriptase Inhibitors were the first therapies to be investigated and still are the major therapies on the market. Entry and Integrase inhibitors were then investigated since 1995 and are now the major therapeutics under clinical development.

Despite the huge increase in HIV market and the needs for new therapies, multiple signals are showing that HIV research and development is running short of new thematic and is practically collapsing since 2005 with a 40% drop in the number of patent applications. This paradox hides multiple scenarios with former leaders becoming followers and new companies emerging on specific or yet unexplored segments. In the same times, new collaborations are forming changing drastically acquired positions between established players.

After 25 years of successes and drawbacks in the treatment of HIV, this IP Overview provides you with a comprehensive panorama of the intellectual property landscape and helps you:

- Position your company’s R&D and IP Portfolio

- Identify key inventors and key players involved in specific thematic and/or therapeutic target

- Understand the collaboration networks and theirs dynamics

- Uncover trends and emerging segments

2009 PDF
Table of Contents
Sample Report
Price: $2,375.00 / €1,587.45

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions